医学
药物治疗
回流
甲氧氯普胺
心动过缓
重症监护医学
新生儿重症监护室
人口
呼吸暂停
麻醉
药品
内科学
儿科
药理学
呕吐
疾病
心率
环境卫生
血压
作者
William Malcolm,C. Michael Cotten
标识
DOI:10.1016/j.clp.2011.12.015
摘要
Pharmacotherapy for gastroesophageal reflux (GER) in neonates, aimed at interfering with this physiologic process and potentially reducing the negative sequelae that providers often attribute to GER, consists primarily of drugs that increase the viscosity of feeds, reduce stomach acidity, or improve gut motility. Medications used to treat clinical signs thought to be from GER, such as apnea, bradycardia, or feeding intolerance, are among the most commonly prescribed medications in neonatal intensive care units in the United States, despite the lack of evidence of safety and efficacy in this population.
科研通智能强力驱动
Strongly Powered by AbleSci AI